Caris Life Sciences (CAI)
18.47
+0.61 (3.42%)
Upcoming Events
Latest Headlines
Form CERT Caris Life Sciences,
June 16, 2026 11:10 AM - SEC Filing
Form 8-A12B Caris Life Sciences,
June 16, 2026 10:47 AM - SEC Filing
Caris Life Sciences dual-lists on NYSE Texas under CAI ticker
June 16, 2026 8:31 AM - StreetInsider
Caris Life Sciences Announces Dual Listing on NYSE Texas
June 16, 2026 8:30 AM - PR NewsWire
Caris Life Sciences authorizes $100 million share repurchase program
June 8, 2026 8:30 AM - StreetInsider
Caris Life Sciences Announces Share Repurchase Program
June 8, 2026 8:30 AM - PR NewsWire
Form 8-K Caris Life Sciences, For: Jun 04
June 5, 2026 5:04 PM - SEC Filing
Form 4 Caris Life Sciences, For: May 29 Filed by: POSTE GEORGE
June 2, 2026 5:44 PM - SEC Filing
Form 4 Caris Life Sciences, For: May 29 Filed by: Knowles Jonathan Kenneth Charles
June 2, 2026 5:43 PM - SEC Filing
Wolfe Research Assumes Caris Life Sciences Inc (CAI) at Peerperform
June 1, 2026 4:01 PM - StreetInsider
Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing
May 26, 2026 8:30 AM - PR NewsWire
Form 4 Caris Life Sciences, For: May 15 Filed by: Denton John Russel
May 18, 2026 4:29 PM - SEC Filing
Form 4 Caris Life Sciences, For: May 15 Filed by: Power Luke Thomas
May 18, 2026 4:28 PM - SEC Filing
Form 4 Caris Life Sciences, For: May 15 Filed by: Brille Brian J
May 18, 2026 4:28 PM - SEC Filing
Form 4 Caris Life Sciences, For: May 15 Filed by: Spetzler David Baxley
May 18, 2026 4:28 PM - SEC Filing
Form 4 Caris Life Sciences, For: May 15 Filed by: HALBERT DAVID D
May 18, 2026 4:28 PM - SEC Filing
Caris Life Sciences study identifies 13,293 patients for new cancer therapies
May 15, 2026 8:32 AM - StreetInsider
Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer Seek
May 15, 2026 8:30 AM - PR NewsWire
Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities
May 13, 2026 8:30 AM - Globe NewsWire
Form SCHEDULE 13G/A Caris Life Sciences, Filed by: TSSP Sub-Fund HoldCo LLC
May 12, 2026 4:31 PM - SEC Filing
Form SCHEDULE 13G/A Caris Life Sciences, Filed by: J H Whitney VI L P
May 12, 2026 10:48 AM - SEC Filing
Form 4 Caris Life Sciences, For: May 11 Filed by: Vacirca Jeff L
May 12, 2026 8:22 AM - SEC Filing
Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels
May 11, 2026 12:15 PM - PR NewsWire
Form 10-Q Caris Life Sciences, For: Mar 31
May 8, 2026 4:14 PM - SEC Filing
Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization
May 8, 2026 4:05 PM - PR NewsWire
Caris Life Sciences Inc (CAI) PT Lowered to $22 at Baird
May 8, 2026 7:55 AM - StreetInsider
Form 8-K Caris Life Sciences, For: May 07
May 7, 2026 4:17 PM - SEC Filing
CAI International (CAI) Tops Q1 EPS by 12c ; Offers Guidance
May 7, 2026 4:11 PM - StreetInsider
Caris Life Sciences Reports First Quarter 2026 Financial Results
May 7, 2026 4:05 PM - PR NewsWire
Caris Life Sciences launches AI-powered breast cancer recurrence test
May 5, 2026 8:32 AM - StreetInsider
Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis
May 5, 2026 8:30 AM - PR NewsWire
Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid Malignancies
May 4, 2026 8:30 AM - PR NewsWire
Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide Benefit in Glioblastoma Patients
April 29, 2026 8:30 AM - PR NewsWire
Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare Conference
April 24, 2026 8:30 AM - PR NewsWire
Form ARS Caris Life Sciences, For: Dec 31
April 23, 2026 6:25 AM - SEC Filing
Form DEFA14A Caris Life Sciences,
April 23, 2026 6:24 AM - SEC Filing
Form DEF 14A Caris Life Sciences, For: Jun 04
April 23, 2026 6:24 AM - SEC Filing
Caris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026
April 20, 2026 8:30 AM - PR NewsWire
Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center
April 17, 2026 8:30 AM - PR NewsWire
Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients
April 15, 2026 8:30 AM - PR NewsWire
'Caris Life Sciences Inc (CAI) is out best value story'; PT Lowered to $31 at TD Cowen
April 13, 2026 8:49 AM - StreetInsider
Jefferies Starts Caris Life Sciences Inc (CAI) at Buy
April 13, 2026 3:24 AM - StreetInsider
Piper Sandler Starts Caris Life Sciences Inc (CAI) at Neutral
April 10, 2026 3:59 AM - StreetInsider
Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients
April 8, 2026 8:30 AM - PR NewsWire
Form SCHEDULE 13G/A Caris Life Sciences, Filed by: FMR LLC
April 7, 2026 1:44 PM - SEC Filing
Caris Life Sciences Inc (CAI) PT Lowered to $30 at Evercore ISI
April 6, 2026 8:16 AM - StreetInsider
Form 8-K Caris Life Sciences, For: Apr 01
April 2, 2026 4:29 PM - SEC Filing
Caris Life Sciences launches ChromoSeq for myeloid cancer testing
April 2, 2026 8:32 AM - StreetInsider
Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies
April 2, 2026 8:30 AM - PR NewsWire
Goldman Sachs Starts Caris Life Sciences Inc (CAI) at Buy
April 1, 2026 5:10 AM - StreetInsider
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect
March 31, 2026 6:00 PM - PR NewsWire
Caris Life Sciences adds AI tools to predict brain metastases risk
March 26, 2026 8:31 AM - StreetInsider
Caris Life Sciences Advances Precision Oncology with New AI Insights Predicting Brain Metastases Risk in Breast and Lung Cancer
March 26, 2026 8:30 AM - PR NewsWire
Caris Life Sciences to Present Six Oncology Studies Utilizing Proprietary Multimodal Data at the AACR Annual Meeting 2026
March 25, 2026 8:30 AM - PR NewsWire
Caris Life Sciences Highlights the Importance of DPYD Testing in Colorectal Cancer During Colorectal Cancer Awareness Month
March 24, 2026 8:30 AM - PR NewsWire
Full Article List
